Babner v. Cumberland County

CourtDistrict Court, M.D. Pennsylvania
DecidedMarch 11, 2022
Docket3:20-cv-02465
StatusUnknown

This text of Babner v. Cumberland County (Babner v. Cumberland County) is published on Counsel Stack Legal Research, covering District Court, M.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Babner v. Cumberland County, (M.D. Pa. 2022).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF PENNSYLVANIA

AARON BABNER,

Plaintiff, CIVIL ACTION NO. 3:20-cv-02465

v. (SAPORITO, M.J.)

CUMBERLAND COUNTY, et al.,

Defendants.

MEMORANDUM This federal civil rights action was commenced when the plaintiff, Aaron Babner, appearing through counsel, filed his fee-paid complaint on December 31, 2020. (Doc. 1.) The complaint names seven defendants: (1) Cumberland County, a Pennsylvania municipality that owns and operates the Cumberland County Correctional Facility (“CCCF”), where Babner was formerly incarcerated as a pretrial detainee; (2) Earl Reitz, the warden of CCCF; (3) Rebekah Finkey, the deputy warden of treatment at CCCF; (4) PrimeCare Medical, Inc. (“PrimeCare”), a Pennsylvania corporation that contracted with CCCF and Cumberland County to provide medical treatment to inmates at CCCF; (5) Michelle Young, a registered nurse employed by PrimeCare to provide medical services to inmates at CCCF; and (6) Sandra Abbey, a psychiatric certified registered nurse practitioner employed by PrimeCare to provide

psychiatric medical services to inmates at CCCF.1 The counseled complaint asserts: (1) § 1983 deliberate indifference to serious medical needs claims against the “medical defendants”2 and the “correctional

officer defendants”3; (2) supplemental state-law medical negligence and corporate liability claims against the medical defendants only; and (3) § 1983 municipal or supervisory liability claims against the “county

defendants”4 and PrimeCare. At the time of filing, Babner was no longer incarcerated. All defendants actually named in the complaint and served with

original process have appeared through counsel to answer the complaint. (Doc. 17; Doc. 18.) The county defendants subsequently moved for judgment on the pleadings, pursuant to Rule 12(c) of the Federal Rules

of Civil Procedure. (Doc. 19). That motion is fully briefed and ripe for

1 The complaint also names several fictitious “John Doe” and “ABC Company” defendants, none of whom have been identified, much less served with original process. 2 The “medical defendants” include PrimeCare, Young, Abbey, and several unidentified and unserved fictious defendants. 3 The “correctional officer defendants” include unidentified and unserved fictious defendants only. 4 The “county defendants” include Cumberland County, Reitz, and Finkey only. decision. (Doc. 20; Doc. 26.)

I. ALLEGATIONS OF THE COMPLAINT On December 14, 2018, Babner was received into custody at CCCF; he was incarcerated as a pretrial detainee based on charges that he had violated a protection from abuse order.5 At the time of his arrival at

CCCF, unspecified medical personnel conducted an intake interview with Babner, who advised that he had been taking Tegretol and gabapentin on a daily basis. The intake interviewer advised Babner that he would

not be receiving his medications because he would only be at CCCF for a short time. Babner explained to unspecified individuals that he needed

these medications, and he further advised that he suffered from asthma. On December 31, 2018, Babner again requested his medications. On January 2, 2019, a second intake interview was conducted by

defendant Young. Babner’s prescriptions were verified with his pharmacy. That verification indicated that, prior to his incarceration, Babner had been prescribed 800 mg of Tegretol twice per day, for a total

daily dosage of 1,600 mg, and he had been prescribed 800 mg of

5 See generally Commonwealth v. Babner, Docket No. CP-21-MD- 0000723-2018 (Cumberland Cty. (Pa.) C.C.P.). gabapentin per day. Young placed an order for Tegretol that same day,

which was approved by defendant Abbey. Because Babner had not taken any Tegretol since his incarceration commenced on December 14, 2018, he should have been treated as if he

had never taken the medication and started on a low initial dose, to be gradually tapered up to avoid serious harm to Babner due to the toxicity of Tegretol. But instead, on January 2, 2019, Babner was prescribed the

full 1,600 mg dosage of Tegretol (800 mg twice daily) immediately. Moreover, after the Tegretol was resumed, bloodwork should have been promptly ordered to monitor Babner’s Tegretol levels and to ensure it was

not at a toxic level. Instead, bloodwork was not ordered and medical personnel ordered that Babner’s Tegretol levels be checked two weeks after he resumed taking it. In addition, beginning on January 2, 2019,

Babner was prescribed 600 mg of gabapentin daily. Babner initially questioned the amounts of Tegretol and gabapentin he was prescribed and advised unidentified medical

personnel that he had been gradually built up to those dosages in the past. His concerns were dismissed by the unidentified medical personnel. Babner was told he must take the prescribed amount, and he was assured that he would not suffer any harm as a result.

On January 3, 2019, Babner received two 800 mg doses of Tegretol and one 600 mg dose of gabapentin. On January 4, 2019, Babner again received two 800 mg doses of Tegretol and one 600 mg dose of gabapentin.

As a result of the excessive amounts of Tegretol and gabapentin he had received, Babner became lethargic, disoriented, and he experienced slurred speech and difficulty walking.

Babner told unidentified correctional officers that he did not think he could go to work because he was unable to perform his work duties. The correctional officers dismissed his concerns. When Babner arrived at

his workplace, his employer questioned whether he had been drinking alcohol. Babner advised him that he was experiencing the effects of his newly resumed prescription medicines. His employer permitted him to

sleep in the back room. When Babner returned to CCCF, he told unidentified correctional officers that he felt “high,” but his concerns were dismissed.

Babner spoke with his mother on the telephone, and she was unable to understand him due to his slurred speech. She called CCCF officials and complained about her son’s condition, but she was told he would go to “the hole” if he refused his medications.

On January 5, 2019, at approximately 2:30 a.m., Babner was sleeping in the top bunk of his cell when, as a result of the excessive amounts of Tegretol and gabapentin in his system, he began to

experience muscle twitches and fell, striking his head on the floor. A “Code Blue” was called and Babner was found by CCCF personnel sitting on the floor, holding a towel to his head, and blood was noted on the floor.

Babner was evaluated by medical personnel, who noted that his pupils were dilated, his mental status was altered, and he was disoriented. They also observed a laceration on his head. CCCF medical personnel initially

placed a cervical collar on Babner, but it was removed because he was vomiting. CCCF medical personnel decided to send him to the emergency

department at Geisinger Holy Spirit Hospital (“Geisinger”) by ambulance. Emergency medical services records reflect that Babner was in and out of consciousness, dizzy, and vomiting, and he was experiencing

severe pain in his head, neck, back, and elbow. Babner was admitted to Geisinger, where various blood tests were performed. These tests revealed that his Tegretol level was toxic at 16.7 ug/mL—a result that was flagged as “critical” because it was well above

the normal reference range of 4 to 12 ug/mL. The blood tests further revealed that Babner had elevated liver function test levels, including a creatine kinase level in excess of 20,000 U/L, which was well in excess of

the normal reference range of 39 to 308 U/L.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Monell v. New York City Dept. of Social Servs.
436 U.S. 658 (Supreme Court, 1978)
City of Oklahoma v. Tuttle
471 U.S. 808 (Supreme Court, 1985)
Burns v. Reed
500 U.S. 478 (Supreme Court, 1991)
United States v. Thomas
86 F.3d 263 (First Circuit, 1996)
Groman v. Township Of Manalapan
47 F.3d 628 (First Circuit, 1995)
Randy Mulholland v. Government County of Berks
706 F.3d 227 (Third Circuit, 2013)
Westport Insurance v. Black, Davis & Shue Agency, Inc.
513 F. Supp. 2d 157 (M.D. Pennsylvania, 2007)
United States Fidelity & Guaranty Co. v. Tierney Associates, Inc.
213 F. Supp. 2d 468 (M.D. Pennsylvania, 2002)
Watson v. Philadelphia Housing Authority
629 F. Supp. 2d 481 (E.D. Pennsylvania, 2009)
Kilvitis v. County of Luzerne
52 F. Supp. 2d 403 (M.D. Pennsylvania, 1999)
Chemi SpA v. GlaxoSmithKline
356 F. Supp. 2d 495 (E.D. Pennsylvania, 2005)
Alston v. Parker
363 F.3d 229 (Third Circuit, 2004)
Gilles v. Davis
427 F.3d 197 (Third Circuit, 2005)
Evancho v. Fisher
423 F.3d 347 (Third Circuit, 2005)

Cite This Page — Counsel Stack

Bluebook (online)
Babner v. Cumberland County, Counsel Stack Legal Research, https://law.counselstack.com/opinion/babner-v-cumberland-county-pamd-2022.